Meta-Analysis: New Oral Anticoagulants vs. Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease
17 May, 2019 | 06:46h | UTC“The efficacy and safety of NOACs as thromboprophylaxis for AF and VHD are similar to those of warfarin.”
“The efficacy and safety of NOACs as thromboprophylaxis for AF and VHD are similar to those of warfarin.”